INVESTORS

17 Mar 2025

Catcher Declares Record NT$15.5 Dividend and Announces Board Nominees

Catcher Technology has declared a record-high cash dividend of NT$15.5 per share for fiscal year 2024 and released its nominee list for the upcoming board election, signaling confidence in its long-term strategy and governance continuity.

Corporate Announcements

Strategic Acquisition of GeneJet’s CDMO Business

Catcher Invests NT$1.75 Billion to Acquire GeneJet’s CDMO Business, Strengthening Presence in Advanced Medical Technologies. Catcher Technology (TWSE: 2474) announced on April 25 that it will acquire the CDMO (Contract Development and Manufacturing Organization) business assets of GeneJet Medical at a total consideration of NT$1.75 billion. The acquired assets will be integrated into Catcher’s subsidiary, Catcher Biotech. GeneJet stated that the sale is part of its strategic shift to realign operations and improve its financial structure.

CDMO Capabilities and Asset Integration

Through a transfer of business assets, Catcher Biotech will gain GeneJet’s CDMO operations, including development resources, process technologies, patent certifications, and an existing customer base related to implantable neuromodulation devices.

OTHER NEWS

07

Mar

2025

Catcher Technology reports consolidated February sales

Revenue Reports & Financial Statements

24

Feb

2025

Catcher Technology reports 2024 Q4 and full-year financial results

Revenue Reports & Financial Statements